Interview: Eduardo Pinto Leite, Director General, GSK Portugal
02.12.2013
Related Interviews
Frédéric Bengold – General Manager, Servier Portugal
Speaking from Servier’s new open-plan office in Lisbon, a space aimed at promoting cross-functional integration and “collective intelligence,” experienced industry executive Frédéric Bengold looks back on three successful years at…
Simão Soares – President, P-BIO
P-BIO, Portugal’s leading association for its biotech industry, is approaching a quarter century in existence. Its president, Simão Soares, tells PharmaBoardroom that there has been “substantial positive change” in the…
Maria do Carmo Neves – President, APOGEN
Erstwhile 21-year CEO of leading Portuguese generics group Tecnimede, Maria do Carmo Neves today serves as president of her country’s generics industry association, APOGEN. She outlines the highly challenging market…
Pfizer Buys Array: A Smart Move?
Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal will give Pfizer…
Is growth in the Taiwanese biotech sector a bubble that is about to burst?
In Taiwan, biotech is finally booming, and more and more of the companies benefitting from this boom are listing on the Gre Tai Securities Market (GTSM), built with small to…
Taiwan: Preparing for takeoff
The past three years have been some of the most eventful in memory for Taiwan’s life sciences industry. At this year’s Bio Taiwan exhibition, the annual conference that invites…
